The state of Kansas has reportedly filed a lawsuit towards pharmaceutical big Pfizer, Inc. PFE, accusing the corporate of violating shopper safety legal guidelines associated to its COVID-19 vaccine.
Kansas Lawyer Basic Kris Kobach argues that Pfizer marketed the vaccine as “secure” regardless of allegedly understanding it was linked to critical opposed occasions.
Citing the 69-page lawsuit submitted to the District Court docket of Thomas County, Fox Enterprise highlights that Pfizer misled the general public by claiming its COVID-19 vaccine was secure and efficient.
Additionally Learn: European Patent Workplace Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech.
The go well with contends that the corporate was conscious of serious security dangers, similar to myocarditis, pericarditis, failed pregnancies, and deaths, but selected to hide this info.
Regardless of understanding the vaccine’s efficacy waned over time and that it didn’t defend towards COVID-19 variants, Pfizer allegedly hid this important effectiveness info from the general public.
Kobach’s go well with asserts that Pfizer’s actions and statements about its COVID-19 vaccine violated the Kansas Shopper Safety Act.
In line with the lawsuit, the corporate’s misrepresentations helped it obtain report revenues of roughly $75 billion in two years.
The go well with highlights that over 3.3 million Pfizer vaccine doses had been administered in Kansas as of February 7, 2024, accounting for greater than 60% of all doses within the state.
Moreover, the lawsuit accuses Pfizer of utilizing varied strategies to hide vaccine security and effectiveness knowledge. These embody confidentiality agreements, prolonged timelines, and the destruction of the management group from its vaccine trials, making it troublesome to match the vaccine’s security and efficacy towards unvaccinated people.
Moreover, Kobach alleges that Pfizer maintained a separate opposed occasions database that contained extra complete knowledge than the Vaccine Hostile Occasion Reporting System.
This database purportedly included spontaneous experiences to Pfizer, well being authority experiences, medical literature instances, and knowledge from Pfizer-sponsored packages.
Worth Motion: PFE shares are down 2.16% at $26.94 eventually test Monday.
Disclaimer: This content material was partially produced with the assistance of AI instruments and was reviewed and revealed by Benzinga editors.
Picture through Shutterstock
